IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q4 2025 Holdings

Filed 2026-02-13 | 2 holdings | $255.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Maze Therapeutics, Inc.(MAZE)COM578784100$185.4M4,473,95872.7%
Tango Therapeutics, Inc.(TNGX)COM87583X109$69.8M7,874,57427.3%